Skip to content

Baxter International BAX Remaining performance obligations related to customer contracts that are unsatisfied or partially unsatisfied

Remaining performance obligations related to customer contracts that are unsatisfied or partially unsatisfied at other companies

Medtronic logo
MedtronicMDT
STERIS logo
STERISSTE
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
Fortive logo
FortiveFTV
Tenet Healthcare logo
Tenet HealthcareTHC

Other financials

Income statement

See full
Revenue$2.7B+2.9%
Gross profit$891.0M+3.5%
Operating income$66.0M+13.8%
Net income-$15.0M-112%
EPS (diluted)-$0.03-112%

Balance sheet

See full
Cash & equivalents$2.0B-12.1%
Total debt$224.0M-8.9%
Total equity$6.0B-14.7%
Total assets$19.8B-6.8%

Cash flow

See full
Operating cash flow$213.0M+210%
CapEx$128.3M+15.0%
Free cash flow$83.0M-42.1%

Valuation

See full
Market cap$10.27B-50.6%
Enterprise value$8.48B-55.6%
P/S0.9×-1.0×

Profitability

See full
Gross margin30.1%-5.9pp
Operating margin-2.7%
Net margin-9.7%+62.5pp
FCF margin3%-2.4pp

Returns & leverage

See full
Return on equity-16.7%-76.7pp
Debt / equity0.0×
Current ratio1.9×-0.2×

Where this comes from

Reported directly by Baxter International in its filing.

Tagged under the XBRL concept us-gaap:RevenueRemainingPerformanceObligation.

The official record: Baxter International’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Baxter International's remaining performance obligations related to customer contracts that are unsatisfied or partially unsatisfied.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Baxter International's remaining performance obligations related to customer contracts that are unsatisfied or partially unsatisfied?
Baxter International (BAX) reported remaining performance obligations related to customer contracts that are unsatisfied or partially unsatisfied of $8.87B in Q1 2026.
How has Baxter International's remaining performance obligations related to customer contracts that are unsatisfied or partially unsatisfied changed year-over-year?
Baxter International's remaining performance obligations related to customer contracts that are unsatisfied or partially unsatisfied decreased by 13.0% year-over-year, from $10.19B to $8.87B.